Literature DB >> 26591192

PREGNANCY AND RENAL TRANSPLANTATION.

David Atallah, Nadine El Kassis, Charbel Salameh, Joelle Safi, Lina Bejjani, Fouad Lutfallah, Wadih Ghaname, Maroun Moukarzel.   

Abstract

Pregnancy is common nowadays in kidney transplant female patients because of medical and surgical advances. However, pregnancy is a high risk one in these patients. Fertility is rapidly restored after the transplantation; thus, contraception is a good option in the first year. Adding to that, pregnancy can endanger the allograft function in the presence of hypertension, a moderate to severe kidney disease and proteinuria. Medical complications are more prevalent in kidney transplant population, such as infections, gestational hypertension and diabetes and anemia. Low birth weight infants and premature delivery are two other major concerns in this population. Acute rejection of the allograft is another major complication that can be avoided with close monitoring of the graft and convenient immunosuppression. Immunosuppressive drugs must be continued during pregnancy except for mycophenolic acid and sirolimus that can be teratogen. Delivery of kidney transplant patients should be vaginal and spontaneous. Cesarean section should be reserved for obstetrical indications. Prophylactic antibiotics should be administered for every invasive procedure. Patients treated with corticosteroids can breastfeed their babies. Kidney donating women can have a safe pregnancy but with a slight risk of gestational diabetes and hypertension. In summary, a multidisciplinary medical team should follow pregnant kidney transplant patients in a tertiary center. International and national registries are a must to collect data concerning this particular high-risk population in order to solve unanswered questions.

Entities:  

Mesh:

Year:  2015        PMID: 26591192     DOI: 10.12816/0015835

Source DB:  PubMed          Journal:  J Med Liban        ISSN: 0023-9852


  1 in total

1.  The influence of intrauterine exposure to immunosuppressive treatment on changes in the immune system in juvenile Wistar rats.

Authors:  Joanna Kabat-Koperska; Agnieszka Kolasa-Wołosiuk; Bartosz Wojciuk; Iwona Wojciechowska-Koszko; Paulina Roszkowska; Barbara Krasnodębska-Szponder; Edyta Paczkowska; Krzysztof Safranow; Edyta Gołembiewska; Bogusław Machaliński; Kazimierz Ciechanowski
Journal:  Drug Des Devel Ther       Date:  2016-07-14       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.